Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis
Abstract:BackgroundThe extent of cortical pathology is an important determinant of multiple sclerosis (MS) severity. Cortical demyelination and neurodegeneration are related to inflammation of the overlying leptomeninges, a more inflammatory CSF milieu and with parenchymal microglia and astroglia activation. These are all components of the compartmentalised inflammatory response. Compartmentalised inflammation is a feature of progressive MS, which is not targeted by disease modifying therapies. Complement is differenti… Show more
“…The rating reflected the most significant cellular infiltrate in the intact leptomeninges and/or perivascular space noted for that case. The extent of leptomeningeal and perivascular infiltration was scored semi-quantitatively as absent = 0; mild (1+, equivalent to 5–30 cells); moderate (2+, equivalent to 30–50 cells); and substantial (3+, equivalent to 50+ cells in a dense infiltrate) in accordance with previous descriptions [ 3 , 25 ]. There were insufficient numbers of cut sections to perform the immunostaining required to confirm if any of the 3+ rated leptomeningeal aggregates represented bona-fide B-cell follicle-like structures.…”
Section: Methodsmentioning
confidence: 80%
“…The immunohistochemical staining protocol methods used are as reported in [ 23 , 25 ]. The antigen retrieval step with 0.05% citraconic anhydride ( v / v ) was conducted on FFPE tissue.…”
Background: Multiple sclerosis (MS) is a clinically heterogeneous disease underpinned by inflammatory, demyelinating and neurodegenerative processes, the extent of which varies between individuals and over the course of the disease. Recognising the clinicopathological features that most strongly associate with disease outcomes will inform future efforts at patient phenotyping. Aims: We used a digital pathology workflow, involving high-resolution image acquisition of immunostained slides and opensource software for quantification, to investigate the relationship between clinical and neuropathological features in an autopsy cohort of progressive MS. Methods: Sequential sections of frontal, cingulate and occipital cortex, thalamus, brain stem (pons) and cerebellum including dentate nucleus (n = 35 progressive MS, females = 28, males = 7; age died = 53.5 years; range 38–98 years) were immunostained for myelin (anti-MOG), neurons (anti-HuC/D) and microglia/macrophages (anti-HLA). The extent of demyelination, neurodegeneration, the presence of active and/or chronic active lesions and quantification of brain and leptomeningeal inflammation was captured by digital pathology. Results: Digital analysis of tissue sections revealed the variable extent of pathology that characterises progressive MS. Microglia/macrophage activation, if found at a higher level in a single block, was typically elevated across all sampled blocks. Compartmentalised (perivascular/leptomeningeal) inflammation was associated with age-related measures of disease severity and an earlier death. Conclusion: Digital pathology identified prognostically important clinicopathological correlations in MS. This methodology can be used to prioritise the principal pathological processes that need to be captured by future MS biomarkers.
“…The rating reflected the most significant cellular infiltrate in the intact leptomeninges and/or perivascular space noted for that case. The extent of leptomeningeal and perivascular infiltration was scored semi-quantitatively as absent = 0; mild (1+, equivalent to 5–30 cells); moderate (2+, equivalent to 30–50 cells); and substantial (3+, equivalent to 50+ cells in a dense infiltrate) in accordance with previous descriptions [ 3 , 25 ]. There were insufficient numbers of cut sections to perform the immunostaining required to confirm if any of the 3+ rated leptomeningeal aggregates represented bona-fide B-cell follicle-like structures.…”
Section: Methodsmentioning
confidence: 80%
“…The immunohistochemical staining protocol methods used are as reported in [ 23 , 25 ]. The antigen retrieval step with 0.05% citraconic anhydride ( v / v ) was conducted on FFPE tissue.…”
Background: Multiple sclerosis (MS) is a clinically heterogeneous disease underpinned by inflammatory, demyelinating and neurodegenerative processes, the extent of which varies between individuals and over the course of the disease. Recognising the clinicopathological features that most strongly associate with disease outcomes will inform future efforts at patient phenotyping. Aims: We used a digital pathology workflow, involving high-resolution image acquisition of immunostained slides and opensource software for quantification, to investigate the relationship between clinical and neuropathological features in an autopsy cohort of progressive MS. Methods: Sequential sections of frontal, cingulate and occipital cortex, thalamus, brain stem (pons) and cerebellum including dentate nucleus (n = 35 progressive MS, females = 28, males = 7; age died = 53.5 years; range 38–98 years) were immunostained for myelin (anti-MOG), neurons (anti-HuC/D) and microglia/macrophages (anti-HLA). The extent of demyelination, neurodegeneration, the presence of active and/or chronic active lesions and quantification of brain and leptomeningeal inflammation was captured by digital pathology. Results: Digital analysis of tissue sections revealed the variable extent of pathology that characterises progressive MS. Microglia/macrophage activation, if found at a higher level in a single block, was typically elevated across all sampled blocks. Compartmentalised (perivascular/leptomeningeal) inflammation was associated with age-related measures of disease severity and an earlier death. Conclusion: Digital pathology identified prognostically important clinicopathological correlations in MS. This methodology can be used to prioritise the principal pathological processes that need to be captured by future MS biomarkers.
“…Immunohistochemistry was performed as described 34 by the authors with diaminobenzidine (Impact DAB; Vector Labs, Newmark, CA, USA) as the chromogen. In all instances, the relevant immunoglobulin G control or the absence of the secondary detection antibody yielded no signal.…”
Section: Methodsmentioning
confidence: 99%
“…Chronic inactive lesions most often presented as sharply demarcated plaques characterized by the presence of human leukocyte antigen + microglia/ macrophages at the lesion border at densities indistinguishable to the surrounding normal appearing tissue. The presence of one or more actively (active or chronic active) demyelinating lesion in the sampled blocks defined a case as harboring “active lesions.” A combined measure of relative leptomeningeal and perivascular immune cell infiltration was reported by assessing the extent of Nissl‐stained infiltrates of the intact cerebral leptomeninges, and perivascular spaces from a minimum of 6 sampled blocks per case according to previously described criteria 34 . The extent of leptomeningeal inflammation was scored semiquantitatively as: absent = 0; mild (1); moderate (2); or substantial (3), to represent the largest single infiltrate observed for that case.…”
Section: Methodsmentioning
confidence: 99%
“…A combined measure of relative leptomeningeal and perivascular immune cell infiltration was reported by assessing the extent of Nissl-stained infiltrates of the intact cerebral leptomeninges, and perivascular spaces from a minimum of 6 sampled blocks per case according to previously described criteria. 34 The extent of leptomeningeal inflammation was scored semiquantitatively as: absent = 0; mild (1); moderate (2); or substantial (3), to represent the largest single infiltrate observed for that case.…”
Section: Assessing the Relative Extent Of Compartmentalized Inflammationmentioning
ObjectiveOlder people with multiple sclerosis (MS) have a less active radiological and clinical presentation, but many still attain significant levels of disability; but what drives worsening disability in this group?MethodsWe used data from the UK MS Register to characterize demographics and clinical features of late‐onset multiple sclerosis (LOMS; symptom onset at ≥50 years), compared with adult‐onset MS (AOMS; onset 18–49 years). We performed a pathology study of a separate MS cohort with a later onset (n = 18, mean age of onset 54 years) versus AOMS (n = 23, mean age of onset 29 years).ResultsIn the Register cohort, there were 1,608 (9.4%) with LOMS. When compared with AOMS, there was a lower proportion of women, a higher proportion of primary progressive MS, a higher level of disability at diagnosis (median MS impact scale 36.7 vs. 28.3, p < 0.001), and a higher proportion of gait‐related initial symptoms. People with LOMS were less likely to receive a high efficacy disease‐modifying treatment and attained substantial disability sooner. Controlling for age of death and sex, neuron density in the thalamus and pons decreased with onset‐age, whereas actively demyelinating lesions and compartmentalized inflammation was greatest in AOMS. Only neuron density, and not demyelination or the extent of compartmentalized inflammation, correlated with disability outcomes in older‐onset MS patients.InterpretationThe more progressive nature of older‐onset MS is associated with significant neurodegeneration, but infrequent inflammatory demyelination. These findings have implications for the assessment and treatment of MS in older people. ANN NEUROL 2023
Clinical, pathological, and imaging evidence in multiple sclerosis (MS) suggests that a smoldering inflammatory activity is present from the earliest stages of the disease and underlies the progression of disability, which proceeds relentlessly and independently of clinical and radiological relapses (PIRA). The complex system of pathological events driving “chronic” worsening is likely linked with the early accumulation of compartmentalized inflammation within the central nervous system as well as insufficient repair phenomena and mitochondrial failure. These mechanisms are partially lesion‐independent and differ from those causing clinical relapses and the formation of new focal demyelinating lesions; they lead to neuroaxonal dysfunction and death, myelin loss, glia alterations, and finally, a neuronal network dysfunction outweighing central nervous system (CNS) compensatory mechanisms. This review aims to provide an overview of the state of the art of neuropathological, immunological, and imaging knowledge about the mechanisms underlying the smoldering disease activity, focusing on possible early biomarkers and their translation into clinical practice. ANN NEUROL 2024
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.